Free T4 is associated with exenatide-related weight loss in patients with type 2 diabetes mellitus and obesity
ConclusionExenatide provides more weight loss in the patients with higher baseline BMI or fT4. Thyroid function remains unchanged during treatment.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research
More News: Byetta | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fortamet | Laboratory Medicine | Metformin | Obesity | Thyroid | Weight Loss